Advertisement

Stabilized Ribavirin diphosphate analogs inhibit the vesicular stomatitis virus (Indiana) in vitro transcription reaction

  • M. J. Lachenmann
  • R. Fernandez-Larsson
  • J. L. Patterson
Conference paper
Part of the Archives of Virology Supplementum book series (ARCHIVES SUPPL, volume 1)

Summary

Ribavirin or Virazole (1-β-D-ribofuranosyl-1,2,4-triazole-3-carboxamide) is a broad-spectrum antiviral agent whose molecular mode of action remains controversial. Results of earlier experiments indicated that ribavirin possesses a significant direct suppressive effect on the vesicular stomatitis virus (Indiana) (VSI) viral polymerase and that this inhibitory activity appears to block initiation of transcription. This direct effect can be mediated by the mono-and diphosphorylated forms of the drug as well as the triphosphorylated form. To confirm our previous results we examined the effects of analogs which stabilize as diphosphates on this VSI virus in vitro transcription reaction; all exhibited inhibitory activity to varying degrees. The results of these studies are discussed in relation to inhibition of primary transcription and its effect on decreased viral progeny production.

Keywords

Antimicrob Agent Vesicular Stomatitis Virus Hemorrhagic Fever With Renal Syndrome Nucleoside Triphosphate Lassa Fever 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Banerjee AK (1981) The in vitro mRNA transcription processes. In: DHL Bishop (ed) Rhabdoviruses, vol 2. CRC Press, Boca Raton, FL, pp 35–50Google Scholar
  2. 2.
    Cassidy LF, Patterson JL (1989) Mechanism of La Crosse virus inhibition by ribavirin. Antimicrob Agents Chemother 33: 2009–2011PubMedGoogle Scholar
  3. 3.
    Eriksson BE, Helgstrand E, Johnnson A, Larsson A, Misiorny JO, Noren L, Philipson K, Stenberg K, Stening G, Stridh S, Oberg B (1977) Inhibition of influenza virus ribonucleic acid polymerase by ribavirin triphosphate. Antimicrob Agents Chemother 11: 946–951PubMedGoogle Scholar
  4. 4.
    Fernandez-Larsson R, O’Connell K, Koumans E, Patterson JL (1989) Investigation of the vesicular stomatitis virus in vitro polymerase reaction using phosphorylated ribavirin. Antimicrob Agents Chemother 33: 1668–1673PubMedGoogle Scholar
  5. 5.
    Fernandez-Larsson R, Patterson JL (1989) Altered ATP function of vesicular stomatitis virus mutant detected by kinetic analysis of the transcriptase using phosphorylated ribavirin. J Gen Virol 70: 2791–2797PubMedCrossRefGoogle Scholar
  6. 6.
    Furman PA, St. Clair MH, Spector T (1984) Acyclovir triphosphate is a suicide inactivator of the herpes simplex virus DNA polymerase. J Biol Chem 259: 9575–9579PubMedGoogle Scholar
  7. 7.
    Goswami BB, Borek E, Sharma OK (1979) The broad spectrum antiviral agent ribavirin inhibits capping of mRNA. Biochem Biophys Res Commun 89: 830–836.PubMedCrossRefGoogle Scholar
  8. 8.
    Jaffe HH, Orchin M (1962) Theory and application of UV spectroscopy. Wiley, New YorkGoogle Scholar
  9. 9.
    Kingsford L, Emerson SU (1980) Transcriptional activities of different phosphorylated species of NS protein purified from vesicular stomatitis virions and cytoplasm of infected cells. J Virol 33: 1097–1105PubMedGoogle Scholar
  10. 10.
    Malinoski F, Stollar F (1981) Inhibitors of IMP dehydrogenase prevent Sindbis virus replication and reduce GTP levels in Aedes albopictus cells. Virology 110: 281–291PubMedCrossRefGoogle Scholar
  11. 11.
    Sidwell RW, Huffman JN, Khard GP, Allen LB, Witkowski JT, Robins RK (1972) Broad spectrum antiviral activity of virazole: 1-β-D-ribofuranosyl-1,2,4-triazole-3carboximide. Science 177: 705–706PubMedCrossRefGoogle Scholar
  12. 12.
    Streeter DG, Witkowski JT, Khare GP, Sidwell RW, Bauer RJ, Robins RK, Simon LN (1973) Mechanism of action of 1-β-D-ribofuranosyl-1,2,4-triazole-3-carboxamide ( Virazole), a new broad-spectrum antiviral agent. Proc Natl Acad Sci USA 70: 1174–1178PubMedCrossRefGoogle Scholar
  13. 13.
    Toltzis P, O’Connell K, Patterson JL (1988) Effect of phosphorylated ribavirin on vesicular stomatitis virus transcription. Antimicrob Agents Chemother 32: 492–497PubMedGoogle Scholar
  14. 14.
    Wray SK, Gilbert BF, Knight V (1985) Effect of ribavirin triphosphate on primed generation and elongation during virus transcription in vitro. Antiviral Res 5: 39–48PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 1990

Authors and Affiliations

  • M. J. Lachenmann
    • 1
  • R. Fernandez-Larsson
    • 1
  • J. L. Patterson
    • 2
  1. 1.Division of Infectious Diseases, Children’s Hospital and Department of Microbiology and Molecular GeneticsHarvard Medical SchoolBostonUSA
  2. 2.Division of Infectious DiseasesChildren’s HospitalBostonUSA

Personalised recommendations